Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption

Por Scheetz, Marc H., Knechtel, Stephanie A., Malczynski, Michael, Postelnick, Michael J., Qi, Chao
Publicado em 2008

Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream Infections

Por Esterly, John S., Griffith, Milena, Qi, Chao, Malczynski, Michael, Postelnick, Michael J., Scheetz, Marc H.
Publicado em 2011

Effect of Differences in MIC Values on Clinical Outcomes in Patients with Bloodstream Infections Caused by Gram-Negative Organisms Treated with Levofloxacin

Por DeFife, Robyn, Scheetz, Marc H., Feinglass, Joe M., Postelnick, Michael J., Scarsi, Kimberly K.
Publicado em 2009

Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification

Por Esterly, John S., Wagner, Jamie, McLaughlin, Milena M., Postelnick, Michael J., Qi, Chao, Scheetz, Marc H.
Publicado em 2012

Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay

Por Scarsi, Kimberly K., Feinglass, Joe M., Scheetz, Marc H., Postelnick, Michael J., Bolon, Maureen K., Noskin, Gary A.
Publicado em 2006

In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii

Por Scheetz, Marc H., Qi, Chao, Warren, John R., Postelnick, Michael J., Zembower, Teresa, Obias, Arlene, Noskin, Gary A.
Publicado em 2007